
Michael Salvatore Conte MD (He/him)
Professor, Surgery, UCSF School of Medicine
Join to view full profile
400 Parnassus AveRm A-581San Francisco, CA 94143
Phone+1 415-353-4363
Dr. Conte is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Conte is a Vascular Surgeon based in San Francisco, CA. He completed his education and training at notable institutions including the Albert Einstein College of Medicine, New York Presbyterian Hospital, and Brigham and Women's Hospital. Dr. Conte has a particular interest and extensive experience in peripheral vascular disease, carotid disease, cerebrovascular disease, aortic surgery, and endovascular surgery. He has published numerous research articles in the field of vascular surgery and has actively participated in various clinical trials. His work has been recognized with honors such as the CMS Meaningful Use Stage 1 Certification and Super Doctor from SuperDoctors.com, and he is a Fellow of the American College of Surgeons.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Vascular Surgery - Independent, 1993 - 1994
New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 1986 - 1993
Albert Einstein College of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 2008 - 2028
MA State Medical License 1989 - 2010
CT State Medical License 1994 - 1998
American Board of Surgery Vascular Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II Start of enrollment: 2014 Feb 01
- The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention Start of enrollment: 2014 Jun 01
- PREDICT-PVI Understanding Peripheral Restenosis: Genomic and Proteomic Determinants of Vascular Intervention Start of enrollment: 2012 Dec 01
Publications & Presentations
PubMed
- Frailty and the efficacy and safety of surgical versus endovascular revascularization: post-hoc analysis of the BEST-CLI trial.Darae Ko, Peter T Evans, Chan Mi Park, Bernet Kato, Maxwell Van Over
The British Journal of Surgery. 2026-07-02 - The Diabetic Foot Consortium Biomarker Platform Study: A New Approach to Advance Diabetic Foot Ulcer Healing.Brian M Schmidt, Cathie Spino, Teresa L Z Jones, Michael Conte, Gayle Gordillo
Advances in Wound Care. 2026-07-01 - 2 citationsManagement of Diabetic Wounds: Expert Panel Consensus Statement.Henry C Hsia, Elof Eriksson, Geoffrey C Gurtner, Aristidis Veves, Osama Hamdy
Advances in Wound Care. 2026-07-01
Journal Articles
- Lower Extremity Revascularization in the Medicare Population: The Ongoing Rise of Office-Based AtherectomySean P Roddy, Michael S Conte, Journal of Vascular Surgery
Authored Content
- Invited CommentaryNovember 2018
- Lower Extremity Revascularization in the Medicare Population: The Ongoing Rise of Office-Based AtherectomyAugust 2018
Press Mentions
SVS Publishes Clinical Practice Guidelines on Management of Intermittent ClaudicationSeptember 24th, 2025
New Clinical Practice Guideline on the Management of Intermittent ClaudicationSeptember 24th, 2025
Updated Intermittent Claudication Guidelines Reflect a Decade of New EvidenceSeptember 12th, 2025
Grant Support
- UCSF Diabetic Foot Clinical Research UnitUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2018–2027
- UCSF Diabetic Foot Clinical Research UnitUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2018–2027
- Prevention of anastomotic intimal hyperplasia by a pro-resolving vascular deviceNational Heart, Lung and Blood Institute2016–2019
- Specialized lipid mediators and mechanisms of resolution in vascular injuryNational Heart Lung and Blood Institute2013–2018
- Survivin: A Novel Regulator Of Intimal Hyperplasia And Vein Graft RemodelingNational Heart, Lung, And Blood Institute2008–2010
Committees
- Co-chair, Lower Extremity Guidelines Committee, Society for Vascular Surgery 2015 - Present
Professional Memberships
- Member
- Member
External Links
- UCSF Vascularhttps://vascular.surgery.ucsf.edu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









